Physician profile
Lee Pennington
NPI 1548259997
$1,158.14
in general payments reported to CMS, 2019-2025
19 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $97.36 · 2023: $19.71 · 2024: $153 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $187.07 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Pfizer INC. | $166.25 | 2019-2025 | |
| Abbvie INC. | $142.90 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $93.90 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $93.15 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $84.49 | 2019 | |
| Lilly USA, LLC | $68.32 | 2025 | Mounjaro |
| Exact Sciences Corporation | $48.45 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $46.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.36 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.28 | 2019-2020 | |
| Novo Nordisk INC | $22.00 | 2019 | |
| Radius Health, INC. | $21.71 | 2025 | Tymlos |
| Vivus LLC | $21.36 | 2019 | |
| Seqirus USA INC | $20.95 | 2025 | Flucelvax, Fluad |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.72 | 2025 | Nexletol |
| Glaxosmithkline, LLC. | $19.71 | 2023 | Shingrix, Arexvy |
| Becton, Dickinson and Company | $17.73 | 2024 | Bd Max System, Bd Max Instrument |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.